Ticker Details
Guardant Health, Inc.
IPO Date:	October 1, 2018
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$15.77B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.71 | 2.75%
Avg Daily Range (30 D):	$2.35 | 2.56%
Avg Daily Range (90 D):	$2.37 | 2.46%

Institutional Daily Volume
Avg Daily Volume:	1.34M
Avg Daily Volume (30 D):	2.03M
Avg Daily Volume (90 D):	1.78M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	62
Avg Trade Size (Sh.) (90 D):	56

Institutional Trades
Total Institutional Trades:	8,976
Avg Institutional Trade:	$3.4M
Avg Institutional Trade (30 D):	$5.41M
Avg Institutional Trade (90 D):	$5.59M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$7.81M
Avg Closing Trade (30 D):	$20.44M
Avg Closing Trade (90 D):	$20.76M
Avg Closing Volume:	139.39K

News

May 20, 2026 @ 4:07 PM Guardant Health Secures FDA Approval For Expanded ... Source: Vandana Singh

May 13, 2026 @ 5:00 PM Global Colorectal Cancer Diagnostics and Therapeut... Source: Delveinsight

May 4, 2026 @ 4:30 PM Pfizer, Arvinas Win FDA Nod For First-Of-Its-Kind ... Source: Vandana Singh

Mar 30, 2026 @ 8:58 AM Oncology Biomarkers Market Trends and Investment O... Source: Researchandmarkets.Com

Mar 13, 2026 @ 1:23 PM Biotech Stock Up 685% Draws $80.5 Million Investme... Source: Jonathan Ponciano

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-3.4	$-.85
Diluted EPS	$-3.4	$-.85
Revenue	$1.08B	$301.67M
Gross Profit	$701.01M	$196.75M
Net Income / Loss	$-433.19M	$-112.08M
Operating Income / Loss	$-447.56M	$-121.35M
Cost of Revenue	$379.2M	$104.92M
Net Cash Flow	$297.1M	$612.02M
PE Ratio